sulbactam has been researched along with Disease Models, Animal in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (6.90) | 18.7374 |
| 1990's | 8 (27.59) | 18.2507 |
| 2000's | 4 (13.79) | 29.6817 |
| 2010's | 11 (37.93) | 24.3611 |
| 2020's | 4 (13.79) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Fu, L; Li, H; Li, X; Liu, J; Luo, S; Wan, Z; Wang, Y; Wu, X; Xie, X; Zhao, Z | 1 |
| Bar-David, E; Ben-Shmuel, A; Glinert, I; Kobiler, D; Levy, H; Schlomovitz, J; Sittner, A; Weiss, S | 1 |
| Alasmari, F; Alhaddad, H; Bell, RL; Sari, Y; Wong, W | 1 |
| Du, L; Long, Y; Shi, H; Shi, L; Sun, L; Wang, H; Xu, H; Zhen, Y; Zhu, J; Zou, B | 1 |
| Durand-Réville, TF; Iyer, R; Miller, A; Moussa, SH; Tommasi, R | 1 |
| Cai, Y; Wang, J; Wang, R; Yang, D | 1 |
| Alshehri, FS; Hakami, AY; Sari, Y | 1 |
| Ahmed, SS; Alp, E; Demiraslan, H; Dinc, G; Doganay, M; Elmali, F; Metan, G | 1 |
| Ikawa, K; Matsumoto, K; Morikawa, N; Nakamura, K; Shigemi, A; Takeda, Y; Ueno, K; Umezaki, Y; Watanabe, E; Yokoyama, Y | 1 |
| Agudelo, M; Gonzalez, JM; Rodriguez, CA; Vesga, O; Zuluaga, AF | 1 |
| Basu, D; Bhattacharya, RN; Dandapat, N; Datta, BK; Kundu, B; Mandal, TK; Mukherjee, P; Nandi, SK; Roy, S; Soundrapandian, C | 1 |
| Docobo-Pérez, F; García-Curiel, A; Ibáñez-Martínez, J; Jiménez-Mejias, ME; Pachón, J; Pachón-Ibáñez, ME; Pichardo, C | 1 |
| Bishop, J; Kellum, JA; Murugan, R; Peng, ZY; Rimmelé, T; Singbartl, K; Srisawat, N; Wang, HZ; Wen, X | 1 |
| Tuğrul, HM; Yıldırım, MI | 1 |
| Chaiworapongsa, T; Cutright, J; Espinoza, J; Fidel, P; Ghezzi, F; Gomez, R; Romero, R; Wolf, N | 1 |
| Docobo-Pérez, F; Fernández-Cuenca, F; Pachón, J; Pachón-Ibáñez, ME; Pascual, A | 1 |
| Bluestone, CD; Cantekin, EI; Doyle, WJ; Kim, HK; Reilly, JS; Rohn, DD; Supance, JS | 1 |
| Coudron, PE; Lavoie, SR; Markowitz, SM; Williams, DS; Wong, ES | 1 |
| Gibbs, RS; Heddleston, L; McDuffie, RS | 1 |
| Blanton, SJ; Charland, SL; Gibbs, RS; McDuffie, RS | 1 |
| Gibbs, RS; McDuffie, RS | 1 |
| Backo, M; Bayer, AS; Burkart, A; Chai, YL; Gaenger, E | 1 |
| Kapukaya, A; Kaya, H; Kesemenli, C; Sari, I; Subasi, M | 1 |
| Caballero, FJ; Cuberos, L; García-Curiel, A; Jiménez-Mejías, ME; Moreno, I; Pachón, J; Pichardo, C; Rodríguez-Hernández, MJ | 1 |
| Blanton, SJ; Gibbs, RS; McDuffie, RS; Shikes, RH | 1 |
| Fasching, CE; Gerding, DN; Moody, JA; Peterson, LR; Sinn, LM | 1 |
| Budinsky, A; Norden, CW | 1 |
| Brook, I | 1 |
29 other study(ies) available for sulbactam and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
In vitro and in vivo assessment of the antibacterial activity of colistin alone and in combination with other antibiotics against Acinetobacter baumannii and Escherichia coli.
Topics: Acinetobacter baumannii; Administration, Intravenous; Animals; Anti-Bacterial Agents; Biofilms; Colistin; Disease Models, Animal; Doripenem; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Meropenem; Mice; Microbial Sensitivity Tests; Monte Carlo Method; Sulbactam; Treatment Outcome; Urinary Tract Infections | 2020 |
Using old antibiotics to treat ancient bacterium-β-lactams for Bacillus anthracis meningitis.
Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Animals; Anthrax; Anti-Bacterial Agents; Bacillus anthracis; Bacteria; beta-Lactamase Inhibitors; beta-Lactams; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Meropenem; Microbial Sensitivity Tests; Piperacillin, Tazobactam Drug Combination; Rabbits; Sulbactam | 2020 |
Ampicillin/Sulbactam Treatment Modulates NMDA Receptor NR2B Subunit and Attenuates Neuroinflammation and Alcohol Intake in Male High Alcohol Drinking Rats.
Topics: Alcohol Drinking; Ampicillin; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Encephalitis; Excitatory Amino Acid Transporter 2; Gene Expression Regulation; HMGB1 Protein; Male; Rats; Receptor for Advanced Glycation End Products; Receptors, N-Methyl-D-Aspartate; Sulbactam | 2020 |
Effects of specific egg yolk immunoglobulin on pan-drug-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Acute Disease; Animals; Anti-Bacterial Agents; Cefoperazone; Dexamethasone; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Egg Yolk; Enzyme-Linked Immunosorbent Assay; Immunoglobulins; Injections, Intraperitoneal; Interleukin-1beta; Male; Mice; Mice, Inbred BALB C; Pneumonia, Bacterial; Sulbactam; Tumor Necrosis Factor-alpha | 2017 |
Acinetobacter baumannii OmpA Is a Selective Antibiotic Permeant Porin.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Outer Membrane Proteins; Biological Transport; Disease Models, Animal; Genetic Fitness; Mice; Porins; Structure-Activity Relationship; Sulbactam | 2018 |
Amikacin and cefoperazone/sulbactam alone or in combination against carbapenem-resistant Pseudomonas aeruginosa.
Topics: Amikacin; Animals; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cefoperazone; Disease Models, Animal; Drug Therapy, Combination; Female; Humans; Luminescent Measurements; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Sulbactam | 2018 |
β-lactams modulate astroglial glutamate transporters and attenuate dependence to CP 55,940, a CB1 receptor agonist, in rat model.
Topics: Amino Acid Transport System X-AG; Ampicillin; Animals; Astrocytes; beta-Lactams; Brain; Cannabinoid Receptor Agonists; Central Nervous System Agents; Cyclohexanols; Disease Models, Animal; Drug-Seeking Behavior; Gene Expression; Male; Rats; Receptor, Cannabinoid, CB1; Substance-Related Disorders; Sulbactam | 2019 |
Efficacy of sulbactam and its combination with imipenem, colistin and tigecycline in an experimental model of carbapenem-resistant Acinetobacter baumannii sepsis.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Bacterial Load; Carbapenems; Colistin; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Imipenem; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Minocycline; Sepsis; Sulbactam; Tigecycline; Time Factors | 2013 |
Pharmacokinetic/pharmacodynamic evaluation of sulbactam against Acinetobacter baumannii in in vitro and murine thigh and lung infection models.
Topics: Abscess; Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Bacterial Load; Disease Models, Animal; Female; Lung; Mice; Microbial Sensitivity Tests; Microbial Viability; Plasma; Pneumonia, Bacterial; Sulbactam; Thigh | 2014 |
An optimized mouse thigh infection model for enterococci and its impact on antimicrobial pharmacodynamics.
Topics: Ampicillin; Anaerobiosis; Animals; Anti-Bacterial Agents; Disease Models, Animal; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Mice, Inbred ICR; Microbial Sensitivity Tests; Mucins; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam; Vancomycin | 2015 |
Development of new localized drug delivery system based on ceftriaxone-sulbactam composite drug impregnated porous hydroxyapatite: a systematic approach for in vitro and in vivo animal trial.
Topics: Animals; Anti-Bacterial Agents; Ceftriaxone; Disease Models, Animal; Drug Compounding; Drug Delivery Systems; Durapatite; Hydrogen-Ion Concentration; Microscopy, Electron, Scanning; Osteomyelitis; Porosity; Powders; Rabbits; Staphylococcus aureus; Sulbactam; X-Ray Diffraction | 2010 |
Efficacy of rifampin, in monotherapy and in combinations, in an experimental murine pneumonia model caused by panresistant Acinetobacter baumannii strains.
Topics: Acinetobacter baumannii; Animals; Anti-Bacterial Agents; Bacterial Load; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Imipenem; Lung; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Microbial Viability; Pneumonia, Bacterial; Rifampin; Rodent Diseases; Sulbactam; Treatment Outcome | 2011 |
Bactericidal antibiotics temporarily increase inflammation and worsen acute kidney injury in experimental sepsis.
Topics: Acute Kidney Injury; Ampicillin; Animals; Anti-Bacterial Agents; Disease Models, Animal; Immunohistochemistry; Inflammation; Kaplan-Meier Estimate; Male; Random Allocation; Rats; Rats, Sprague-Dawley; Reference Values; Risk Assessment; Sepsis; Statistics, Nonparametric; Sulbactam; Survival Rate; Time Factors | 2012 |
[Assessment of efficacies of imipenem, cefoperazone-sulbactam and cefepime in rats with experimental thigh abscess model with multidrug resistant and susceptible Acinetobacter baumannii strains].
Topics: Abscess; Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Cefepime; Cefoperazone; Cephalosporins; Colony Count, Microbial; Disease Models, Animal; Drug Combinations; Drug Resistance, Multiple, Bacterial; Female; Imipenem; Random Allocation; Rats; Rats, Wistar; Serum Bactericidal Test; Soft Tissue Infections; Sulbactam; Thigh | 2011 |
The effect of antibiotic therapy on intrauterine infection-induced preterm parturition in rabbits.
Topics: Ampicillin; Animals; Body Temperature; Disease Models, Animal; Drug Therapy, Combination; Escherichia coli Infections; Female; Fetal Membranes, Premature Rupture; Injections, Intramuscular; Pregnancy; Pregnancy Complications, Infectious; Rabbits; Random Allocation; Sulbactam | 2003 |
Prevention of rifampicin resistance in Acinetobacter baumannii in an experimental pneumonia murine model, using rifampicin associated with imipenem or sulbactam.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Imipenem; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mutation; Pneumonia, Bacterial; Rifampin; Sulbactam | 2006 |
Treatment of ampicillin-resistant acute otitis media in the chinchilla.
Topics: Acute Disease; Ampicillin; Animals; Chinchilla; Disease Models, Animal; Haemophilus Infections; Haemophilus influenzae; Otitis Media; Penicillanic Acid; Penicillin Resistance; Sulbactam | 1983 |
Comparison of ampicillin-sulbactam with vancomycin for treatment of experimental endocarditis due to a beta-lactamase-producing, highly gentamicin-resistant isolate of Enterococcus faecalis.
Topics: Ampicillin; Animals; Aortic Valve; beta-Lactamases; Disease Models, Animal; Drug Resistance, Microbial; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecalis; Female; Gentamicins; Gram-Positive Bacterial Infections; Rabbits; Sulbactam; Vancomycin | 1993 |
A rabbit model for ascending infection in pregnancy: intervention with indomethacin and delayed ampicillin-sulbactam therapy.
Topics: Ampicillin; Animals; Chorioamnionitis; Disease Models, Animal; Drug Therapy, Combination; Escherichia coli Infections; Female; Indomethacin; Pregnancy; Pregnancy Complications, Infectious; Premedication; Rabbits; Sulbactam; Time Factors; Treatment Outcome; Uterine Cervical Diseases | 1993 |
The effect of timing of single-dose transplacental ampicillin-sulbactam therapy for prevention of neonatal group B streptococcal colonization and bacteremia in a rabbit model.
Topics: Ampicillin; Animals; Animals, Newborn; Bacteremia; Disease Models, Animal; Drug Therapy, Combination; Female; Oropharynx; Pregnancy; Rabbits; Streptococcal Infections; Streptococcus agalactiae; Sulbactam; Time Factors | 1996 |
Ascending group B streptococcal genital infection in the rabbit model.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Therapy, Combination; Female; Genital Diseases, Female; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Rabbits; Streptococcal Infections; Streptococcus agalactiae; Sulbactam | 1996 |
Treatment of experimental staphylococcal endocarditis due to a strain with reduced susceptibility in vitro to vancomycin: efficacy of ampicillin-sulbactam.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Resistance, Microbial; Drug Therapy, Combination; Endocarditis, Bacterial; Microbial Sensitivity Tests; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Sulbactam; Vancomycin | 1999 |
Effect of granulocyte-macrophage colony-stimulating factor on treatment of acute osteomyelitis. An experimental investigation in rats.
Topics: Acute Disease; Ampicillin; Animals; Biopsy, Needle; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Granulocyte-Macrophage Colony-Stimulating Factor; Injections, Intramuscular; Osteomyelitis; Radionuclide Imaging; Rats; Rats, Sprague-Dawley; Sensitivity and Specificity; Staphylococcus aureus; Sulbactam; Treatment Outcome | 2001 |
Sulbactam efficacy in experimental models caused by susceptible and intermediate Acinetobacter baumannii strains.
Topics: Acinetobacter; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Disease Models, Animal; Endocarditis; Heart Valves; Imipenem; Lung; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Pneumonia; Rabbits; Sulbactam; Survival Rate; Time Factors | 2001 |
A rabbit model for bacterially induced preterm pregnancy loss: intervention studies with ampicillin-sulbactam.
Topics: Ampicillin; Animals; Disease Models, Animal; Drug Therapy, Combination; Escherichia coli Infections; Female; Fetal Death; Injections, Intramuscular; Pregnancy; Pregnancy Complications, Infectious; Progesterone; Rabbits; Sulbactam; Time Factors | 1991 |
Treatment evaluation of experimental staphylococcal infections: comparison of beta-lactam, lipopeptide, and glycopeptide antimicrobial therapy.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Cefamandole; Cefoperazone; Cephalothin; Daptomycin; Disease Models, Animal; Female; Glycopeptides; Oxacillin; Peptides; Rabbits; Staphylococcal Infections; Sulbactam; Teicoplanin; Vancomycin | 1990 |
Treatment of experimental chronic osteomyelitis due to Staphylococcus aureus with ampicillin/sulbactam.
Topics: Ampicillin; Animals; Chronic Disease; Disease Models, Animal; Drug Therapy, Combination; Microbial Sensitivity Tests; Osteomyelitis; Rabbits; Sodium Morrhuate; Staphylococcal Infections; Sulbactam | 1990 |
In vitro susceptibility and in vivo efficacy of antimicrobials in the treatment of Bacteroides fragilis-Escherichia coli infection in mice.
Topics: Abscess; Ampicillin; Animals; Anti-Bacterial Agents; Bacteroides fragilis; Bacteroides Infections; Cefamandole; Cefotetan; Cefoxitin; Ceftizoxime; Cilastatin; Cilastatin, Imipenem Drug Combination; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Imipenem; Male; Mice; Skin Diseases; Sulbactam | 1989 |